The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landais, E.
Right arrow Articles by Houssaint, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landais, E.
Right arrow Articles by Houssaint, E.
The Journal of Immunology, 2006, 177: 1427-1433.
Copyright © 2006 by The American Association of Immunologists

EBV-Specific CD4+ T Cell Clones Exhibit Vigorous Allogeneic Responses1

Elise Landais*, Alexis Morice*, Heather M. Long{dagger}, Tracey A. Haigh{dagger}, Béatrice Charreau{ddagger}, Marc Bonneville*, Graham S. Taylor{dagger} and Elisabeth Houssaint2,*

* Institut National de la Santé et de la Recherche Médicale, Unité 601, Institut de Biologie, Nantes, France; {dagger} Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, United Kingdom; and {ddagger} Institut National de la Santé et de la Recherche Médicale, Unité 643, Institut de Transplantation et de Recherche en Transplantation, Centre Hospitalier Universitaire Hôtel-Dieu, Nantes, France

Alloreactive T cells play a key role in mediating graft-vs-host disease and allograft rejection, and recent data suggest that most T cell alloreactivity resides within the CD4 T cell subset. Particularly, T cell responses to herpesvirus can shape the alloreactive repertoire and influence transplantation outcomes. In this study, we describe six distinct EBV-specific CD4+ T cell clones that cross-reacted with EBV-transformed lymphoblastoid cell lines (LCLs), dendritic cells, and endothelial cells expressing MHC class II alleles commonly found in the population. Allorecognition showed exquisite MHC specificity. These CD4+ T cell clones efficiently killed dendritic cells or LCLs expressing the cross-reactive allogeneic MHC class II molecules, whereas they did not kill autologous LCLs. Endothelial cells expressing the proper allogeneic MHC molecules were poorly killed, but they induced high-level TNF-{alpha} production by the EBV-specific CD4+ T cell clones. As already proposed, the strong alloreactivity toward LCLs suggest that these cells could be used for selective depletion of alloreactive T cells.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
L. K. Selin and M. A. Brehm
Frontiers in Nephrology: Heterologous Immunity, T Cell Cross-Reactivity, and Alloreactivity
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2268 - 2277.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.